Prediabetes is not an approved indication for any GLP-1 medication. Where these drugs are used in people with prediabetes, it is because obesity or another qualifying condition is present. Coverage follows that, not the prediabetes, and this catches people out constantly.
Prediabetes is not diabetes, and a prescription written on a diabetes indication you do not have is a false claim on your record. It stays there, and it can affect life and disability insurance underwriting for years afterward.
For how this fits alongside the other comparisons, and what actually decides the choice, see Comparing GLP-1 Medications: How to Actually Choose.
What prediabetes means
Blood glucose above normal but below the diabetes threshold, identified by A1c or fasting glucose. It indicates raised risk of progression rather than an established diagnosis.
Not everyone with prediabetes progresses, and weight loss meaningfully reduces the chance. That is the reasoning behind treating it, and it is a preventive argument rather than a treatment one.
What is established
Structured lifestyle intervention reduces progression to type 2 diabetes, and the evidence for that is strong and long-standing.
Weight loss by any means improves glycaemic markers. GLP-1 medications produce weight loss, so the improvement follows.
What is less settled is the long-term picture: whether medication-driven prevention holds after stopping, given that weight regain is common. That matters because prediabetes is often identified in people who would need many years of treatment.
Getting it covered
The request rests on BMI and comorbidities, not on the prediabetes itself.
Prediabetes appears on some payers’ accepted comorbidity lists for the BMI 27 to 29.9 band, and not on others. Where it does count, it usually needs lab confirmation rather than a mention in your notes. Check your plan’s clinical policy.
Where metformin comes in
Metformin is sometimes used to reduce progression risk, particularly alongside lifestyle change. It is inexpensive and long-established.
Its weight effect is modest. Where cost or coverage is the constraint, it is a reasonable option to discuss.
The part that gets skipped
Structured lifestyle programmes work, are often covered when medication is not, and are frequently available through employers or health systems at low cost.
They are also usually what a plan wants documented before approving anything else, so doing one serves two purposes.
Prediabetes is not a diabetes indication, and why coverage follows the indication explains what that means in practice. Where it counts as a comorbidity at all is covered in do you need a comorbidity, and metformin is the option often offered instead.
Frequently asked questions
Will a GLP-1 reverse prediabetes?
Weight loss improves glycaemic markers. Durability after stopping is less established.
Does prediabetes qualify me for coverage?
Sometimes as a comorbidity alongside BMI, depending on the plan. Not on its own.
Can my doctor write diabetes instead?
No. That is a false claim with consequences for you and the prescriber.
Should I try lifestyle change first?
It works, and your plan may require documented participation anyway.
Is metformin a reasonable option?
Often discussed, inexpensive, with a smaller weight effect.
What if I stop the medication?
Weight regain is common, and glycaemic markers tend to follow. Worth planning for rather than discovering.